Authors:
ISHIGOOKA J
SUGIYAMA T
SUZUKI M
KOBAYASHI K
TAKEUCHI H
MURASAKI M
Citation: J. Ishigooka et al., SURVIVAL ANALYTIC APPROACH TO LONG-TERM PRESCRIPTION OF BENZODIAZEPINE HYPNOTICS, Psychiatry and clinical neurosciences ( Psychiatry and clinical neurosciences (Carlton. Print)), 52(5), 1998, pp. 541-545
Authors:
ISHIGOOKA J
IWAO M
SUZUKI M
FUKUYAMA Y
MURASAKI M
MIURA S
Citation: J. Ishigooka et al., DEMOGRAPHIC FEATURES OF PATIENTS SEEKING COSMETIC SURGERY, PSYCHIATRY AND CLINICAL NEUROSCIENCES, 52(3), 1998, pp. 283-287
Authors:
UCHIYAMA K
FURUNO K
SHIZUMA T
SUGITA M
KATO M
TOKITA Y
MURASAKI M
HASHIMOTO N
TAKAHASHI H
KOMATSUBARA T
MATSUURA K
TANAKA T
SASAKI Y
Citation: K. Uchiyama et al., MEASUREMENT OF THE LIFETIME OF THE FIRST 2(-124() STATE IN BA), EUROPEAN PHYSICAL JOURNAL A-HADRONS AND NUCLEI, 2(1), 1998, pp. 13-15
Authors:
YOKOTA S
KUMAGAI Y
ISAWA S
WATANABE T
SAWADA M
MURASAKI M
NAKAI K
KANNAMI A
Citation: S. Yokota et al., PHARMACOKINETICS OF MIZOLASTINE, A NOVEL ANTIALLERGIC DRUG, IN THE ELDERLY, Naunyn-Schmiedeberg's archives of pharmacology, 358(1), 1998, pp. 4727-4727
Citation: M. Murasaki, PHASE-II STUDY RESULTS OF AD-5423, A NEWLY SYNTHESIZED SDA NEUROLEPTIC IN JAPAN, Psychopharmacology bulletin, 33(3), 1997, pp. 560-560
Authors:
ISHIGOOKA J
NAGATA E
TAKAHASHI A
SUGIYAMA T
UCHIUMI M
TSUKAHARA T
MURASAKI M
MIURA S
OGUMA T
YANO Y
Citation: J. Ishigooka et al., SIMULTANEOUS MONITORING OF INHIBITION OF SEROTONIN UPTAKE BY PLATELETS AND PLASMA DRUG CONCENTRATIONS FOLLOWING ADMINISTRATION OF DULOXETINE, A NEW ANTIDEPRESSANT CANDIDATE, TO HEALTHY-VOLUNTEERS, Current therapeutic research, 58(10), 1997, pp. 679-692
Authors:
KONDO Y
KOSHIBA Y
ARIMA Y
MURASAKI M
YAMADA T
AMISHIRO H
MORI H
KYUMA K
Citation: Y. Kondo et al., A 1.2-GFLOPS NEURAL-NETWORK CHIP FOR HIGH-SPEED NEURAL-NETWORK SERVERS, IEEE journal of solid-state circuits, 31(6), 1996, pp. 860-864
Citation: M. Suzuki et al., A COMPARATIVE-STUDY OF THE PSYCHOLOGICAL EFFECTS OF DN-2327, A PARTIAL BENZODIAZEPINE AGONIST, AND ALPRAZOLAM, Psychopharmacology, 121(4), 1995, pp. 442-450
Citation: M. Murasaki, OVERVIEW OF SEROTONIN 1A RECEPTOR-SELECTIVE AGENTS IN ANXIETY DISORDERS - THE DEVELOPMENTAL SITUATION IN JAPAN, International review of psychiatry, 7(1), 1995, pp. 105-113
Authors:
TAKAHASHI A
SUZUKI M
WAKATABE H
ISHIGOUOKA J
INAMI M
MURASAKI M
Citation: A. Takahashi et al., PHASE-I STUDY OF VIGABATRIN - EFFECTS ON PSYCHOMOTOR FUNCTION, Japanese journal of psychiatry and neurology, 48(2), 1994, pp. 340-341
Authors:
YOSHIDA Y
OHTANI Y
KAWAGUCHI T
MURASAKI M
MIURA S
Citation: Y. Yoshida et al., SERUM ALPHA-1-ANTICHYMOTRYPSIN CONCENTRATIONS IN ALZHEIMER TYPE AND VASCULAR DEMENTIA, Neurobiology of aging, 15, 1994, pp. 190000093-190000094
Authors:
ISHIGOOKA J
MURASAKI M
MIURA S
SHIBATA M
TAKAMATSU R
Citation: J. Ishigooka et al., PILOT-STUDY OF PLASMA-CONCENTRATIONS OF MOSAPRAMINE, A NEW IMINODIBENZYL ANTIPSYCHOTIC AGENT, AFTER MULTIPLE ORAL-ADMINISTRATION IN SCHIZOPHRENIC-PATIENTS, Current therapeutic research, 55(3), 1994, pp. 331-342
Authors:
OHTANI Y
SHIMADA E
MURASAKI M
OGUCHI T
MIURA S
Citation: Y. Ohtani et al., PHASE-I SINGLE-DOSE STUDY OF SABELUZOLE - COMPARATIVE-STUDY IN HEALTHY-YOUNG VS ELDERLY VOLUNTEERS, Neuropsychopharmacology, 9(2), 1993, pp. 190000056-190000057
Citation: M. Murasaki et al., EFFICACY OF A NEW ANXIOLYTIC, TANDOSPIRONE (SM-3997) ON NEUROSIS - A COMPARATIVE DOUBLE-BLIND-STUDY WITH DIAZEPAM, Neuropsychopharmacology, 9(2), 1993, pp. 190000125-190000125